• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

NAKAMURA Takafumi  中村 貴史

ORCIDConnect your ORCID iD *help
… Alternative Names

NAKAMUTA Takahumi  中村 貴史

中村 貴史  ナカムラ タカフミ

Less
Researcher Number 70432911
Other IDs
Affiliation (Current) 2025: 鳥取大学, 医学部, 教授
Affiliation (based on the past Project Information) *help 2022 – 2024: 鳥取大学, 医学部, 教授
2020 – 2023: 鳥取大学, 医学部, 准教授
2011 – 2023: 鳥取大学, 医学(系)研究科(研究院), 准教授
2015: 鳥取大学, 医学学研究科, 准教授
2013: 鳥取大学, 医学部, 准教授 … More
2011 – 2012: 鳥取大学, 医学系研究科, 准教授
2010 – 2011: 東京大学, 医科学研究所, 特任准教授
2007: The University of Tokyo, 医科学研究所, 客員研究員
2006: 九大, 生体防御医学研究所, 研究員 Less
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / Medium-sized Section 90:Biomedical engineering and related fields / Tumor therapeutics / Clinical oncology / Tumor biology and related fields / Tumor immunology / General surgery / Pathological medical chemistry
Except Principal Investigator
Basic Section 56010:Neurosurgery-related / Basic Section 55020:Digestive surgery-related / Basic Section 53030:Respiratory medicine-related / Tumor therapeutics / General surgery
Keywords
Principal Investigator
バイオテクノロジー / 癌 / ウイルス療法 / 遺伝子治療 / トランスレーショナルリサーチ / ドラッグデリバリー / ウイルス / バイオマーカー / がん / 免疫回避 … More / 生体機能利用 / 抗体 / 腫瘍微小環境 / 光感受性遺伝子 / 光線力学的療法 / がんウイルス療法 / 免疫活性化 / 腫瘍治療学 / 抗腫瘍免疫 / トランスレーションリサーチ / トランスレーショナルリサ ーチ / 実験外科学 … More
Except Principal Investigator
ワクシニアウイルス / ウイルス療法 / 遺伝子治療 / ウイルスベクター / intracerebral model / glioma / vaccinia oncolytic virus / Glioma261-Nluc / 脳内移植マウス / FUVAC / 免疫応答 / 膵癌 / MET阻害 / テポチニブ / MET阻害薬 / 腫瘍溶解性ウイルス / 免疫療法 / 肺癌 / 癌幹細胞 / 分子標的薬 / 癌治療 / 樹状細胞 / 細胞療法 / トランスレーショナルリサーチ / 科学教育 / 細胞医療 / 再生医療 / トランスレーショナル・リサーチ Less
  • Research Projects

    (17 results)
  • Research Products

    (182 results)
  • Co-Researchers

    (15 People)
  •  Development of oncolytic virotherapy combined with photodynamic therapyPrincipal Investigator

    • Principal Investigator
      中村 貴史
    • Project Period (FY)
      2023 – 2024
    • Research Category
      Grant-in-Aid for Challenging Research (Exploratory)
    • Review Section
      Medium-sized Section 90:Biomedical engineering and related fields
    • Research Institution
      Tottori University
  •  膵癌に対するがん治療用ウイルスを用いた革新的治療法の開発

    • Principal Investigator
      坂本 照尚
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 55020:Digestive surgery-related
    • Research Institution
      Tottori University
  •  Examination of treatment effect of next generation vaccinia oncolytic virus with a C6 glioma intracerebral transplantation model

    • Principal Investigator
      神部 敦司
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56010:Neurosurgery-related
    • Research Institution
      Tottori University
  •  Next-generation cancer virotherapy via integrative understanding and regulation of the tumor microenvironmentPrincipal Investigator

    • Principal Investigator
      中村 貴史
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Tottori University
  •  Systemic delivery of oncolytic vaccinia virus to tumorsPrincipal Investigator

    • Principal Investigator
      NAKAMURA Takafumi
    • Project Period (FY)
      2021 – 2022
    • Research Category
      Grant-in-Aid for Challenging Research (Exploratory)
    • Review Section
      Medium-sized Section 90:Biomedical engineering and related fields
    • Research Institution
      Tottori University
  •  Combined molecular targeting and immunotherapy for lung cancer with MET inhibition and vaccinia virus therapy

    • Principal Investigator
      Kanaji Nobuhiro
    • Project Period (FY)
      2019 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 53030:Respiratory medicine-related
    • Research Institution
      Kagawa University
  •  Novel strategy of cancer virotherapy for radical cure of both primary and metastatic tumorsPrincipal Investigator

    • Principal Investigator
      NAKAMURA Takafumi
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Tottori University
  •  A novel oncolytic virotherapy for paclitaxel resistant ovarian cancerPrincipal Investigator

    • Principal Investigator
      NAKAMURA Takafumi
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Challenging Research (Exploratory)
    • Research Field
      Tumor biology and related fields
    • Research Institution
      Tottori University
  •  Tumor-targeted MAPK-dependent recombinant vaccinia virus for oncolytic virotherapyPrincipal Investigator

    • Principal Investigator
      NAKAMURA Takafumi
    • Project Period (FY)
      2015 – 2017
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Tumor therapeutics
    • Research Institution
      Tottori University
  •  Tumor-specific and Systemic Oncolytic Vaccinia Virus for Novel Cancer TherapyPrincipal Investigator

    • Principal Investigator
      Nakamura Takafumi
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Tumor therapeutics
    • Research Institution
      Tottori University
  •  The development of gene therapy for breast cancer using targeted measles virus vectors

    • Principal Investigator
      Matsumura Yumiko
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Tumor therapeutics
    • Research Institution
      Kyushu University
  •  Novel cancer therapy using microRNA-regulated oncolytic viruses targeting cancer stem cellsPrincipal Investigator

    • Principal Investigator
      Nakamura Takafumi
    • Project Period (FY)
      2012 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Clinical oncology
    • Research Institution
      Tottori University
  •  Development of tumor-targeted therapy using lentivirus-displayed antibody libraryPrincipal Investigator

    • Principal Investigator
      NAKAMURA Takafumi
    • Project Period (FY)
      2012 – 2013
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Tumor immunology
    • Research Institution
      Tottori University
  •  Development of quality prediction / rationalization system in autologous cell therapy which can conquer individual difference

    • Principal Investigator
      KATANO HISAKO
    • Project Period (FY)
      2010 – 2013
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  Development of tumor-targeted therapy using measles virus-displayed antibody libraryPrincipal Investigator

    • Principal Investigator
      NAKAMURA Takafumi
    • Project Period (FY)
      2010 – 2011
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      General surgery
    • Research Institution
      The University of Tokyo
  •  MicroRNA Targeting of Oncolytic Viruses for cancer therapyPrincipal Investigator

    • Principal Investigator
      NAKAMURA Takafumi
    • Project Period (FY)
      2010 – 2011
    • Research Category
      Grant-in-Aid for Young Scientists (A)
    • Research Field
      Clinical oncology
    • Research Institution
      Tottori University
      The University of Tokyo
  •  腫瘍溶解能と腫瘍特異的感染能を持つ弱毒化麻疹ウイルスによる肺癌標的治療法の開発Principal Investigator

    • Principal Investigator
      中村 貴史
    • Project Period (FY)
      2006 – 2007
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Pathological medical chemistry
    • Research Institution
      The University of Tokyo
      Kyushu University

All 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2008 2007 Other

All Journal Article Presentation Book Patent

  • [Book] 腫瘍内科:特集 新しいがん免疫療法研究の展開と臨床応用2023

    • Author(s)
      中村貴史
    • Total Pages
      6
    • Publisher
      科学評論社
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Book] 遺伝子治療の新局面2019

    • Author(s)
      中村貴史
    • Total Pages
      7
    • Publisher
      医歯薬出版株式会社
    • ISBN
      4910204770394
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Book] 先端治療技術の実用化と開発戦略2017

    • Author(s)
      中村貴史
    • Total Pages
      8
    • Publisher
      技術情報協会
    • ISBN
      9784861047473
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Book] 次世代がん治療 : 発症・転移メカニズムからがん免疫療法・ウイルス療法、診断法まで2017

    • Author(s)
      中村貴史
    • Total Pages
      7
    • Publisher
      エヌ・ティー・エス
    • ISBN
      9784860435035
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Book] 先端治療技術の実用化と開発戦略2017

    • Author(s)
      中村貴史
    • Total Pages
      8
    • Publisher
      技術情報協会
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Book] 次世代がん治療 : 発症・転移メカニズムからがん免疫療法・ウイルス療法、診断法まで2017

    • Author(s)
      中村貴史
    • Total Pages
      7
    • Publisher
      エヌ・ティー・エス
    • ISBN
      9784860435035
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Book] ワクシニアウイルス(遺伝子医学 MOOK30号)2016

    • Author(s)
      中村貴史
    • Publisher
      株式会社メディカルドゥ
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Book] 臨床・創薬利用が見えてきたmiRcroRNA 「miRNA制御ウイルスによるがん細胞特異的治療法の開発」の項2012

    • Author(s)
      中村貴史
    • Total Pages
      6
    • Publisher
      株式会社メディカルドゥ
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Book] 臨床・創薬利用が見えてきたmiRcroRNA「miRNA制御ウイルスによるがん細胞特異的治療法の開発」の項2012

    • Author(s)
      中村貴史
    • Total Pages
      6
    • Publisher
      株式会社メディカルドウ
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Book] miRNA制御ウイルスによるがん細胞特異的治療法の開発.遺伝子医学MOOK23号2012

    • Author(s)
      中村貴史
    • Publisher
      落谷孝広監修、株式会社メディカルドゥ
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Book] 麻疹ウイルスによるがん治療法の開発臨床とウイルス2010

    • Author(s)
      中村貴史
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Book] Chapter of Molecular targeting in oncology : Engineering Oncolytic Measles Viruses for Targeted Cancer Therapy.2008

    • Author(s)
      Nakamura T, Russell SJ
    • Total Pages
      724
    • Publisher
      Humana Press
    • Data Source
      KAKENHI-PROJECT-18799009
  • [Journal Article] Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment2021

    • Author(s)
      Nakatake M, Kuwano N, Kaitsurumaru E, Kurosaki H, Nakamura T
    • Journal Title

      Molecular Therapy

      Volume: 29 Issue: 5 Pages: 1782-1793

    • DOI

      10.1016/j.ymthe.2020.12.024

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Journal Article] Anti-Tumor Effects of MAPK-Dependent Tumor-Selective Oncolytic Vaccinia Virus Armed with CD/UPRT against Pancreatic Ductal Adenocarcinoma in Mice2021

    • Author(s)
      Kurosaki H, Nakatake M, Sakamoto T, Kuwano N, Yamane M, Ishii K, Fujiwara Y, Nakamura T
    • Journal Title

      Cells

      Volume: 10 Issue: 5 Pages: 985-985

    • DOI

      10.3390/cells10050985

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Journal Article] Intratumoral Expression of IL-7 and IL-12 Using an Oncolytic Virus Increases Systemic Sensitivity to Immune Checkpoint Blockade2020

    • Author(s)
      Nakao S, Arai Y, Tasaki M, Yamashita M, Murakami R, Kawase T, Amino N, Nakatake M, Kurosaki H, Mori M, Takeuchi M, Nakamura T
    • Journal Title

      Science Translational Medicine

      Volume: 12 Issue: 526

    • DOI

      10.1126/scitranslmed.aax7992

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Journal Article] lncRNA UCA1-Mediated Cdc42 Signaling Promotes Oncolytic Vaccinia Virus Cell-to-Cell Spread in Ovarian Cancer2019

    • Author(s)
      Horita Kosuke、Kurosaki Hajime、Nakatake Motomu、Kuwano Nozomi、Oishi Tetsuro、Itamochi Hiroaki、Sato Sho、Kono Hiromichi、Ito Mai、Hasegawa Kosei、Harada Tasuku、Nakamura Takafumi
    • Journal Title

      Molecular Therapy - Oncolytics

      Volume: 13 Pages: 35-48

    • DOI

      10.1016/j.omto.2019.03.003

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K19597, KAKENHI-PROJECT-15H04310
  • [Journal Article] Partial Deletion of Glycoprotein B5R Enhances Vaccinia Virus Neutralization Escape while Preserving Oncolytic Function2019

    • Author(s)
      Nakatake Motomu、Kurosaki Hajime、Kuwano Nozomi、Horita Kosuke、Ito Mai、Kono Hiromichi、Okamura Tomotaka、Hasegawa Kosei、Yasutomi Yasuhiro、Nakamura Takafumi
    • Journal Title

      Molecular Therapy - Oncolytics

      Volume: 14 Pages: 159-171

    • DOI

      10.1016/j.omto.2019.05.003

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03515, KAKENHI-PROJECT-17H04079
  • [Journal Article] Long noncoding RNA UCA1 enhances sensitivity to oncolytic vaccinia virus by sponging miR-18a/miR-182 and modulating the Cdc42/filopodia axis in colorectal cancer2019

    • Author(s)
      Horita Kosuke、Kurosaki Hajime、Nakatake Motomu、Ito Mai、Kono Hiromichi、Nakamura Takafumi
    • Journal Title

      Biochemical and Biophysical Research Communications

      Volume: 516 Issue: 3 Pages: 831-838

    • DOI

      10.1016/j.bbrc.2019.06.125

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Journal Article] Efficacy and Safety of Doubly-Regulated Vaccinia Virus in a Mouse Xenograft Model of Multiple Myeloma2017

    • Author(s)
      Muneyoshi Futami, Kota Sato, Kanji Miyazaki, Kenshi Suzuki, Takafumi Nakamura and Arinobu Tojo
    • Journal Title

      Molecular Therapy Oncolytics

      Volume: 6 Pages: 57-68

    • DOI

      10.1016/j.omto.2017.07.001

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Journal Article] 腫瘍特異的に増殖する遺伝子組換えワクシニアウイルス2016

    • Author(s)
      中村貴史
    • Journal Title

      実験医学

      Volume: 34 Pages: 31-37

    • Data Source
      KAKENHI-PROJECT-26640103
  • [Journal Article] ワクシニアウイルス2016

    • Author(s)
      中村 貴史
    • Journal Title

      遺伝子医学MOOK

      Volume: 30

    • Data Source
      KAKENHI-PROJECT-24300340
  • [Journal Article] 腫瘍特異的に増殖する遺伝子組換えワクシニアウイルス2016

    • Author(s)
      中村 貴史
    • Journal Title

      実験医学

      Volume: 34 Pages: 31-37

    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Journal Article] 腫瘍特異的に増殖する遺伝子組換えワクシニアウイルス2016

    • Author(s)
      中村 貴史
    • Journal Title

      実験医学

      Volume: 34 Pages: 31-37

    • Data Source
      KAKENHI-PROJECT-24300340
  • [Journal Article] Combined Cytolytic Effects of a Vaccinia Virus Encoding a Single Chain Trimer of MHC-I with a Tax-Epitope and Tax-Specific CTLs on HTLV-I-Infected Cells in a Rat Model2014

    • Author(s)
      Ohashi T, Nakamura T, Kidokoro M, Zhang X, Shida H
    • Journal Title

      BioMed Research International.

      Volume: 2014 Pages: 902478-902478

    • DOI

      10.1155/2014/902478

    • NAID

      120005434503

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-24300340, KAKENHI-PROJECT-24590547, KAKENHI-PROJECT-24650629, KAKENHI-PROJECT-26640103
  • [Journal Article] Antibody neutralization of retargeted measles viruses2014

    • Author(s)
      Lech PJ, Pappoe R, Nakamura T, Russell SJ
    • Journal Title

      Virology

      Volume: 454-455 Pages: 237-246

    • DOI

      10.1016/j.virol.2014.01.027

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24650629, KAKENHI-PROJECT-24300340, KAKENHI-PROJECT-26640103
  • [Journal Article] Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties that Is Active Against Lung Adenocarcinoma2012

    • Author(s)
      Miyamoto S, Inoue H, Nakamura T, Yamada M, Sakamoto C, Urata Y, Okazaki T, Marumoto T, Takahashi A, Takayama K, Nakanishi Y, Shimizu H, Tani K
    • Journal Title

      Cancer Research

      Volume: (掲載確定)(印刷中) Issue: 10 Pages: 2609-2621

    • DOI

      10.1158/0008-5472.can-11-3185

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22659227, KAKENHI-PROJECT-23590465, KAKENHI-PROJECT-23659331, KAKENHI-PROJECT-23790446, KAKENHI-PROJECT-24300340, KAKENHI-PROJECT-24650629
  • [Journal Article] Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma2012

    • Author(s)
      Miyamoto S, Inoue H, Nakamura T, Yamada M, Sakamoto C, Urata Y, Okazaki T, Marumoto T, Takahashi A, Takayama K, Nakanishi Y, Shimizu H and Tani K.
    • Journal Title

      Cancer Res

      Volume: 72 Pages: 2609-2621

    • Data Source
      KAKENHI-PROJECT-22659227
  • [Journal Article] A novel real-time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses2011

    • Author(s)
      Katano H, Kano M, Nakamura T, Kanno T, Asanuma H, Sata T
    • Journal Title

      Journal of Medical Virology

      Volume: 83 Pages: 322-330

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390243
  • [Journal Article] CD133 suppresses neuroblastoma cell differentiation via signal pathway modification2011

    • Author(s)
      Takenobu H, Shimozato O, Nakamura T, Ochiai H, Yamaguchi Y, Ohira M, Nakagawara A, Kamijo T
    • Journal Title

      Oncogene

      Volume: 30 Pages: 97-105

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Journal Article] MicroRNA regulation of vaccinia virus for enhanced oncolytic activity and reduced pathogenicity in oncolytic virotherapy2011

    • Author(s)
      Hikichi M, Kidokoro M, Haraguchi T, Iba H, Shida H, Tahara H & Nakamura T.
    • Journal Title

      Molecular Therapy

      Volume: 19巻 Issue: 6 Pages: 1107-15

    • DOI

      10.1038/mt.2011.36

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249069, KAKENHI-PROJECT-22659227, KAKENHI-PROJECT-22680065, KAKENHI-PROJECT-22700873, KAKENHI-PUBLICLY-23130504
  • [Journal Article] MicroRNA-based gene regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy2011

    • Author(s)
      Hikichi M, Minoru Kidokoro M, Haraguchi T, Iba H, Shida H, Tahara H, Nakamura T
    • Journal Title

      Molecular Therapy

      Volume: 19 Pages: 1107-1115

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Journal Article] MicroRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy2011

    • Author(s)
      Hikichi M, Minoru Kidokoro M, Haraguchi T, Iba H, Shida H, Tahara H and Nakamura T
    • Journal Title

      Molecular Therapy

      Volume: 19 Pages: 1107-1115

    • Data Source
      KAKENHI-PROJECT-22659227
  • [Journal Article] CD133 suppresses neuroblastoma cell differentiation via signal pathway modification2011

    • Author(s)
      Takenobu H, Shimozato O, Nakamura T, Ochiai H, Yamaguchi Y, Ohira M, Nakagawara A, Kamijo T
    • Journal Title

      Oncogene

      Volume: 30 Issue: 1 Pages: 97-105

    • DOI

      10.1038/onc.2010.383

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21390317, KAKENHI-PROJECT-21591376, KAKENHI-PROJECT-21790397, KAKENHI-PROJECT-22680065, KAKENHI-PROJECT-22791017
  • [Journal Article] Enhanced Antitumor Effects of an Engineered Measles Virus Edmonston Strain Expressing the Wild-type N, P, L Genes on Human Renal Cell Carcinoma.2010

    • Author(s)
      Meng X, Nakamura T, Okazaki T, Inoue H, Takahashi A, Miyamoto S, Sakaguchi G, Eto M, Naito S, Takeda M, Yanagi Y andTani K.
    • Journal Title

      Molecular Therapy

      Volume: 18 Issue: 3 Pages: 544-551

    • DOI

      10.1038/mt.2009.296

    • Data Source
      KAKENHI-PROJECT-22680065
  • [Journal Article] Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer2010

    • Author(s)
      Katoh M, Kazuki Y, Kazuki K, Kajitani N, Takiguchi M, Nakayama Y, Nakamura T, Oshimura M
    • Journal Title

      BMC Biotechnology

      Volume: 10

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Journal Article] Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer2010

    • Author(s)
      Motonobu Katoh, Yasuhiro Kazuki, Kanako Kazuki, Naoyo Kajitani, Masato Takiguchi, Yuji Nakayama, Takafumi Nakamura, Mitsuo Oshimura
    • Journal Title

      BMC Biotechnology

      Volume: Vol.10 Issue: 1 Pages: 37-48

    • DOI

      10.1186/1472-6750-10-37

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22500426, KAKENHI-PROJECT-22680065
  • [Journal Article] Enhanced Antitumor Effects of an Engineered Measles Virus Edmonston Strain Expressing the Wild-type N, P, L Genes on Human Renal Cell Carcinoma2010

    • Author(s)
      Meng X, Nakamura T, Okazaki T, Inoue H, Takahashi A, Miyamoto S, Sakaguchi G, Eto M, Naito S, Takeda M, Yanagi Y, Tani K
    • Journal Title

      Molecular Therapy

      Volume: 18 Pages: 544-551

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Journal Article] Affinity threholds for membrane fusion triggering by viral glycoproteins.2007

    • Author(s)
      Hasegawa K, Hu C, Nakamura T, Marks JD, Russell SJ, Peng KW.
    • Journal Title

      Journal of Virology 81

      Pages: 13149-13157

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18799009
  • [Journal Article] Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas.2007

    • Author(s)
      Wei J, Wahl J, Nakamura T, Stiller D, Mertens T, Hampl W, Debatin KM, Beltinger
    • Journal Title

      Gene Therapy 14

      Pages: 1573-1586

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18799009
  • [Journal Article] Epidermal Growth Factor Receptor (EGFR)-Retargeted Measles Virus Strains Effectively Target EGFR- or EGFRvIII Expressing Gliomas.2007

    • Author(s)
      Paraskevakou G, Allen C, Nakamura T, Zollman P, James CD, Peng KW, Schroeder M, Russell SJ, Galanis E
    • Journal Title

      Molecular Therapy 15

      Pages: 677-686

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18799009
  • [Patent] 新規遺伝子組換えワクシニアウイルス及びその利用2021

    • Inventor(s)
      中村貴史, 飼鶴丸恵美, 中武大夢, 黒崎創
    • Industrial Property Rights Holder
      鳥取大学
    • Industrial Property Rights Type
      特許
    • Filing Date
      2021
    • Overseas
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Patent] 新規遺伝子組換えワクシニアウイルス及びその利用2020

    • Inventor(s)
      中村貴史、飼鶴丸恵美、中武大夢、黒崎創
    • Industrial Property Rights Holder
      鳥取大学
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2020-191128
    • Filing Date
      2020
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Patent] 細胞融合を誘導するワクシニアウイルス及びその利用2020

    • Inventor(s)
      中村貴史、桑野望、中武大夢、黒崎創
    • Industrial Property Rights Holder
      鳥取大学、 (株)エボル ブ・バイオセラ
    • Industrial Property Rights Type
      特許
    • Filing Date
      2020
    • Overseas
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Patent] 細胞融合を誘導するワクシニアウイルス及びその利用2019

    • Inventor(s)
      中村貴史、桑野望、中武大夢、黒﨑創
    • Industrial Property Rights Holder
      鳥取大学、(株)エボルブ・バイオセラピューティクス
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2019-091609
    • Filing Date
      2019
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Patent] 外来遺伝子発現ワクシニアウイルスの製造方法2017

    • Inventor(s)
      中村貴史、中武大夢、黒﨑創、堀田享佑
    • Industrial Property Rights Holder
      鳥取大学
    • Industrial Property Rights Type
      特許
    • Filing Date
      2017
    • Overseas
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Patent] ワクシニアウイルスの増殖・伝搬を増強する宿主制御因子2017

    • Inventor(s)
      中村 貴史,堀田 享佑,黒崎 創,中武 大夢
    • Industrial Property Rights Holder
      国立大学法人鳥取大学
    • Industrial Property Rights Type
      特許
    • Filing Date
      2017
    • Acquisition Date
      2018
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Patent] 外来遺伝子発現ワクシニアウイルスの製造方法2016

    • Inventor(s)
      中村貴史、中武 大夢、黒崎 創、堀田享佑
    • Industrial Property Rights Holder
      鳥取大学
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2016-138712
    • Filing Date
      2016-07-13
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Patent] ワクシニアウイルスの増殖・伝搬を増強する宿主制御因子2016

    • Inventor(s)
      中村貴史、堀田享佑、黒崎 創、中武大夢
    • Industrial Property Rights Holder
      鳥取大学
    • Industrial Property Rights Type
      特許
    • Filing Date
      2016-07-22
    • Overseas
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Patent] ワクシニアウイルスの増殖・伝搬を増強する宿主制御因子2015

    • Inventor(s)
      中村 貴史、堀田 享佑、黒﨑 創、中武 大夢
    • Industrial Property Rights Holder
      鳥取大学
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2015-145153
    • Filing Date
      2015-07-22
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Patent] ワクシニアウイルスの増殖・伝搬を増強する宿主制御因子2015

    • Inventor(s)
      中村 貴史、堀田 享佑、黒﨑 創、 中武 大夢
    • Industrial Property Rights Holder
      鳥取大学
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2015-145153
    • Filing Date
      2015-07-22
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Patent] 分裂促進因子活性化タンパク質キナーゼ依存性組換えワクシニアウイルス(MD-RVV)及びその使用2014

    • Inventor(s)
      中村 貴史
    • Industrial Property Rights Holder
      国立大学法人 鳥取大学
    • Industrial Property Rights Type
      特許
    • Filing Date
      2014-11-20
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Patent] 分裂促進因子活性化タンパク質キナーゼ依存性組換えワクシニアウイルス(MD-RVV)及びその使用2013

    • Inventor(s)
      中村貴史
    • Industrial Property Rights Holder
      国立大学法人鳥取大学、一般財団法人化学及血清療法研究所
    • Industrial Property Rights Type
      特許
    • Filing Date
      2013-11-22
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Patent] 分裂促進因子活性化タンパク質キナーゼ依存性組換えワクシニアウイルス(MD-RVV)及びその使用2013

    • Inventor(s)
      中村貴史
    • Industrial Property Rights Holder
      中村貴史
    • Industrial Property Rights Type
      特許
    • Filing Date
      2013-11-22
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Patent] マイクロRNA制御組換えワクシニアウイルス及びその使用2011

    • Inventor(s)
      中村貴史, 他4名
    • Industrial Property Rights Holder
      東京大学, 他2者
    • Filing Date
      2011-03-15
    • Overseas
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Patent] マイクロRNA制御組換えワクシニアウイルス及びその使用2011

    • Inventor(s)
      中村貴史、引地美奈、田原秀晃、志田 壽利、木所 稔
    • Industrial Property Rights Holder
      国立大学法人東京大学、国立大学法人北海道大学
    • Filing Date
      2011-03-15
    • Overseas
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Patent] マイクロRNA制御組換えワクシニアウイルス及びその使用2010

    • Inventor(s)
      中村貴史、引地美奈、田原秀晃、志田 壽利、木所 稔
    • Industrial Property Rights Holder
      国立大学法人東京大学、国立大学法人北海道大学
    • Industrial Property Number
      2010-090662
    • Filing Date
      2010-04-09
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Patent] マイクロRNA制御組換えワクシニアウイルス及びその使用2010

    • Inventor(s)
      中村貴史, 他4名
    • Industrial Property Rights Holder
      東京大学, 他2者
    • Industrial Property Number
      2010-090662
    • Filing Date
      2010-04-09
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] 次世代がん治療用遺伝子組換えワクシニアウイルスの開発と臨床展開2022

    • Author(s)
      中村貴史
    • Organizer
      第81回日本癌学会学術総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] 次世代腫瘍溶解性ワクシニアウイルスによる腫瘍微小環境の統合的制御を介したウイルス療法の新戦略2022

    • Author(s)
      中村貴史
    • Organizer
      第28回日本遺伝子細胞治療学会
    • Invited
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] Next-generation oncolytic vaccinia viral platform2022

    • Author(s)
      Nakamura T
    • Organizer
      14th International Oncolytic Virotherapy Conference
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response and sensitivity to immune checkpoint blockade by remodeling the tumor microenvironment2021

    • Author(s)
      Nakatake M, Kuwano N, Kaitsurumaru E, Kurosaki H, Nakamura T
    • Organizer
      第27回日本遺伝子細胞治療学会
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] Oncolytic vaccinia virus carrying IL-7 and IL-12 alters intratumoral TCR repertoire, systemically sensitizing tumors to immune checkpoint blockade2021

    • Author(s)
      Nakao S, Tasaki M, Yamashita M, Nakamura T
    • Organizer
      第27回日本遺伝子細胞治療学会
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] 日本発がん治療用ウイルスによる次世代バイオ創薬2021

    • Author(s)
      中村 貴史
    • Organizer
      日本薬学会創薬セミナー
    • Invited
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] Novel Poxvirus Vectors2021

    • Author(s)
      Nakamura T
    • Organizer
      24th Annual Meeting of American Society of Gene & Cell Therapy
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] Fusogenic oncolytic vaccinia virus changes the tumor immune microenvironment by cell fusion and enhances systemic anti-tumor immunity2020

    • Author(s)
      Nakatake M, Kuwano N, Kaitsurumaru E, Kurosaki H, Nakamura T
    • Organizer
      23th Annual Meeting of American Society of Gene & Cell Therapy
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] Oncolytic vaccinia virus encoding IL-7 and IL-12 systemically sensitizes tumors to anti-PD-1 antibody in a syngeneic mouse model2020

    • Author(s)
      Nakao S, Yamashita M, Tasaki M, Kawase T, Nakatake M, Kurosaki H, Mori M, Takeuchi M, Nakamura T
    • Organizer
      Annual Meeting of American Association for Cancer Research 2020
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment2020

    • Author(s)
      Nakamura T
    • Organizer
      第79回日本癌学会
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] 日本発がん治療用ウイルスの創薬2019

    • Author(s)
      中村貴史
    • Organizer
      金沢大学薬学シンポジウム2019
    • Invited
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] Next-generation oncolytic vaccinia virus for cancer virotherapy2019

    • Author(s)
      Nakamura T
    • Organizer
      国際遺伝子細胞治療シンポジウムIGCT
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] LncRNA UCA1 is a potential biomarker of response to oncolytic virotherapy as well as chemotherapy for ovarian cancer2019

    • Author(s)
      Nakamura T
    • Organizer
      第78回日本癌学会
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Presentation] LncRNA UCA1 is a potential biomarker of response to oncolytic vaccinia virotherapy and chemotherapy for ovarian cancer2019

    • Author(s)
      Horita K, Kurosaki H, Nakatake M, kuwano N, Ishii K, Kohno H, Ito M, Itamochi H, Oishi T, Harada T, Nakamura T
    • Organizer
      第25回日本遺伝子治療学会
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Presentation] Next-generation oncolytic vaccinia virus for cancer virotherapy2019

    • Author(s)
      Nakamura T
    • Organizer
      Asia Pacific Consortium of Gene and Cell Therapy 2019
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] 日本発がん治療用ウイルスの創薬2019

    • Author(s)
      中村貴史
    • Organizer
      金沢大学薬学シンポジウム2019
    • Invited
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Presentation] Tumor-specific replication-competent oncolytic vaccinia virus with stealth effect by engineering viral glycoprotein B5R2019

    • Author(s)
      Nakatake M, Kurosaki H, Nakamura T
    • Organizer
      The 12th International Oncolytic Virotherapy Conference
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] Next-generation oncolytic vaccinia virus for cancer virotherapy2019

    • Author(s)
      Nakamura T
    • Organizer
      国際遺伝子細胞治療シンポジウムIGCT
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Presentation] LncRNA UCA1 is a potential biomarker of response to oncolytic virotherapy as well as chemotherapy2019

    • Author(s)
      Horita K, Kurosaki H, Nakamura T
    • Organizer
      The 12th International Oncolytic Virotherapy Conference
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Presentation] Novel approach for systemic cancer virotherapy by using oncolytic vaccinia virus2019

    • Author(s)
      Nakatake M, Kurosaki H, Nakamura T
    • Organizer
      第25回日本遺伝子治療学会
    • Data Source
      KAKENHI-PROJECT-19H03515
  • [Presentation] 腫瘍溶解性ウイルスによるがんウイルス療法の現状と展望2018

    • Author(s)
      中村 貴史
    • Organizer
      第3回日本遺伝子細胞学会若手研究会セミナー
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] Preclinical toxicological evaluation of tumor-targeted and armed oncolytic vaccinia virus in cynomolgus monkey2018

    • Author(s)
      Kurosaki H, Okamura T, Ito M, Nakatake M, Kuwano N, Horita K, Ishii K, Kohno H, Yasutomi Y, Nakamura T
    • Organizer
      第24回日本遺伝子細胞治療学会
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] Novel approach for systemic cancer therapy with oncolytic vaccinia virus through evading the host immune response2018

    • Author(s)
      Nakatake M, Kurosaki H, Nakamura T
    • Organizer
      第24回日本遺伝子細胞治療学会
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] がんのみを標的破壊するワクシニアウイルスベクターの開発2018

    • Author(s)
      中村 貴史
    • Organizer
      日本薬学会 第138年会
    • Invited
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Presentation] Predictive biomarkers for cancer virotherapy with oncolytic vaccinia virus2018

    • Author(s)
      Horita K, Kurosaki H, Nakatake M, Kuwano N, Ishii K, Kohno H, Ito M, Itamochi H, Oishi T, Harada T, Nakamura T
    • Organizer
      第24回日本遺伝子細胞治療学会
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] がんのみを標的破壊するワクシニアウイルスベクターの開発2018

    • Author(s)
      中村 貴史
    • Organizer
      日本薬学会 第138年
    • Invited
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] Novel Approach for Systemic Cancer Therapy with Oncolytic Vaccinia Virus through Evading the Host Immune Response2018

    • Author(s)
      Nakatake M, Kurosaki H, Nakamura T
    • Organizer
      21th Annual Meeting of American Society of Gene & Cell Therapy
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] Predictive biomarkers for cancer virotherapy with oncolytic vaccinia virus2018

    • Author(s)
      Horita K, Kurosaki H, Nakatake M, Kuwano N, Ishii K, Kohno H, Ito M, Itamochi H, Oishi T, Harada T, Nakamura T
    • Organizer
      第24回日本遺伝子細胞治療学会
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Presentation] 難治性がんを標的破壊する遺伝子組換えワクシニアウイルスによるがんウイルス療法の開発2017

    • Author(s)
      中村 貴史
    • Organizer
      第2回日本遺伝子細胞学会若手研究会セミナー
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] 難治性がんを標的破壊する武装化遺伝子組換えワクシニアウイルスによる全身性がんウイルス療法の開発2017

    • Author(s)
      中村 貴史
    • Organizer
      第76回日本癌学会学術総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] Tumor-targeted and armed oncolytic vaccinia virus for systemic cancer virotherapy2017

    • Author(s)
      Nakamura T
    • Organizer
      第23回日本遺伝子細胞治療学会
    • Invited
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] IncRNA UCA1 has the potential to be a biomarker of therapeutic response to oncolytic vaccinia virus in paclitaxel resistant ovarian cancer2017

    • Author(s)
      Horita K, Kurosaki H, Nakatake M, Kuwano N, Ishii K, Itamochi H, Oishi T, Harada T, Nakamura T
    • Organizer
      第23回日本遺伝子細胞治療学会
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] IncRNA UCA1 has the potential to be a biomarker of therapeutic response to oncolytic vaccinia virus in paclitaxel resistant ovarian cancer.2017

    • Author(s)
      Horita K, Kurosaki H, Nakatake M, Kuwano N, Ishii K, Itamochi H, Oishi T, Harada T, Nakamura T.
    • Organizer
      第23回日本遺伝子細胞治療学会
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Presentation] Tumor-targeted and armed oncolytic vaccinia virus for systemic cancer virotherapy2017

    • Author(s)
      Nakamura T
    • Organizer
      第23回日本遺伝子細胞治療学会
    • Invited
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Presentation] 難治性がんを標的破壊する武装化遺伝子組換えワクシニアウイルスによる全身性がんウイルス療法の開発2017

    • Author(s)
      中村 貴史
    • Organizer
      第76回日本癌学会学術総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Presentation] Preclinical Study of Tumor-targeted and Armed Oncolytic Vaccinia Virus for Systemic Cancer Virotherapy2017

    • Author(s)
      Nakatake M, Kurosaki H, Horita K, Kuwano N, Ishii K, Nomura M, Sakamoto T, Okamura T, Yasutomi Y, Nakamura T
    • Organizer
      20th Annual Meeting of American Society of Gene & Cell Therapy
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] Tumor-targeting and CD/UPRT-armed oncolytic vaccinia virus enhanced their therapeutic efficacy by combination with prodrug 5-FC2017

    • Author(s)
      Nakatake M, Kuwano N, Horita K, Ishii K, Sakamoto T, Kurosaki H, Nakamura T
    • Organizer
      第23回日本遺伝子細胞治療学会
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] 分子生物学的アプローチを駆使してウイルスを知り、そしてがん治療に利用する2017

    • Author(s)
      中村 貴史
    • Organizer
      第40回日本分子生物学会年会
    • Invited
    • Data Source
      KAKENHI-PROJECT-17K19597
  • [Presentation] Preclinical toxicological evaluation of tumor-targeted and armed oncolytic vaccinia virus in cynomolgus monkey2017

    • Author(s)
      Kurosaki H, Okamura T, Nakatake M, Kuwano N, Horita K, Ishii K, Yasutomi Y, Nakamura T
    • Organizer
      第23回日本遺伝子細胞治療学会
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] 分子生物学的アプローチを駆使してウイルスを知り、そしてがん治療に利用する2017

    • Author(s)
      中村 貴史
    • Organizer
      第40回日本分子生物学会年
    • Invited
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] Tumor-targeted and armed oncolytic vaccinia virus for systemic virotherapy2016

    • Author(s)
      Nakamura T
    • Organizer
      第75回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜市)
    • Year and Date
      2016-10-08
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Presentation] Upregulated lncRNA-UCA1 enhances therapeutic effect of oncolytic vaccinia virus in paclitaxel resistant ovarian cancer2016

    • Author(s)
      Horita K, Kurosaki H, Nakatake M, kuwano N, Ishii K, Parada R, Nomura M, Itamochi H, Oishi T, Harada T and Nakamura T
    • Organizer
      第22回日本遺伝子細胞治療学会
    • Place of Presentation
      東京慈恵会医科大学(東京都)
    • Year and Date
      2016-07-29
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] Preclinical study for tumor-targeted and armed oncolytic vaccinia virus for systemic cancer virotherapy2016

    • Author(s)
      Nakatake M, Kurosaki H, Yamane M, Horita K, Ishii K, kuwano N, Hasegawa K, Fujiwara K, Nomura M, Parada R and Nakamura T
    • Organizer
      第22回日本遺伝子細胞治療学会
    • Place of Presentation
      東京慈恵会医科大学(東京都)
    • Year and Date
      2016-07-29
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] Preclinical study for tumor-targeted and armed oncolytic vaccinia virus for systemic cancer virotherapy2016

    • Author(s)
      Nakamura T, Nakatake M, Horita K, Ishii K, kuwano N, Nomura M and Kurosaki H
    • Organizer
      10th International Conference on Oncolytic Viruses As Cancer Therapeutics
    • Place of Presentation
      Fairmont Waterfront Hotel (Vancouver, Canada)
    • Year and Date
      2016-10-03
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] Upregulated lncRNA-UCA1 enhances therapeutic effect of oncolytic vaccinia virus in paclitaxel-resistant human malignant tumors2016

    • Author(s)
      Nakamura T, Horita K, Nakatake M, kuwano N, Ishii K, Nomura M and Kurosaki H
    • Organizer
      10th International Conference on Oncolytic Viruses As Cancer Therapeutics
    • Place of Presentation
      Fairmont Waterfront Hotel (Vancouver, Canada)
    • Year and Date
      2016-10-02
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] Identification of host factors required for enhancing replication and spread of oncolytic vaccinia virus2015

    • Author(s)
      Horita K, Nakatake M, Goto I, Yamane M, Okazaki M, Parada R, Kurosaki H, Nakamura T
    • Organizer
      The 21st Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      大阪国際会議場(大阪市)
    • Year and Date
      2015-07-25
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Presentation] Tumor-specific, replication-competent vaccinia virus for systemic oncolytic virotherapy2015

    • Author(s)
      Nakamura T
    • Organizer
      The 21st Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      大阪国際会議場(大阪市)
    • Year and Date
      2015-07-24
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Presentation] 難治性がんを標的破壊する遺伝子組換えワクシニアウイルスによる全身性がんウイルス療法の開発2015

    • Author(s)
      中村 貴史
    • Organizer
      第74回日本癌学会学術総会
    • Place of Presentation
      名古屋国際会議場(名古屋市)
    • Year and Date
      2015-10-10
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Presentation] 純和製ワクシニアウイルスを用いた難治がんに対するウイルス療法の開発2015

    • Author(s)
      中村 貴史
    • Organizer
      第23回遺伝子治療推進産学懇話会
    • Place of Presentation
      京都大学東京オフィス(東京都)
    • Year and Date
      2015-04-10
    • Invited
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] 難治性がんを標的破壊する遺伝子組換えワクシニアウイルスによる全身性がんウイルス療法の開発2015

    • Author(s)
      中村 貴史
    • Organizer
      第74回日本癌学会学術総会
    • Place of Presentation
      名古屋国際会議場(名古屋市)
    • Year and Date
      2015-10-09
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Presentation] Tumor-specific, replication-competent vaccinia virus for systemic oncolytic virotherapy2015

    • Author(s)
      Nakamura T
    • Organizer
      The 21st Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      大阪国際会議場(大阪市)
    • Year and Date
      2015-07-24
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] 純和製ワクシニアウイルスを用いた難治がんに対するウイルス療法の開発2015

    • Author(s)
      中村 貴史
    • Organizer
      第23回遺伝子治療推進産学懇話会
    • Place of Presentation
      京都大学東京オフィス(東京都)
    • Year and Date
      2015-04-10
    • Invited
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Presentation] Enhancing tumor specificity and therapeutic index of oncolytic vaccinia virus through deletions of both VGF and O1 protein genes2015

    • Author(s)
      Nakatake M, Yamane M, Parada R, Horita K, Okazaki M, Hasegawa K, Miyara A, Fujiwara K, Kurosaki H, Nakamura T
    • Organizer
      The 21st Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      大阪国際会議場(大阪市)
    • Year and Date
      2015-07-25
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Presentation] Enhancing tumor specificity and therapeutic index of oncolytic vaccinia virus through deletions of both VGF and O1 protein genes2015

    • Author(s)
      Nakatake M, Yamane M, Parada R, Horita K, Okazaki M, Hasegawa K, Miyara A, Fujiwara K, Kurosaki H, Nakamura T
    • Organizer
      The 21st Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      大阪国際会議場(大阪市)
    • Year and Date
      2015-07-25
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] Deletions of both vaccinia growth factor and O1 protein genes enhance therapeutic index of oncolytic vaccinia virus2015

    • Author(s)
      Nakatake M, Yamane M, Horita K, Okazaki M, Roxana Parada R, Hajime Kurosaki H, Nakamura T
    • Organizer
      9th International Conference on Oncolytic Viruses As Cancer Therapeutics
    • Place of Presentation
      Boston Park Plaza Hotel(Boston, USA)
    • Year and Date
      2015-06-15
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Presentation] Identification of host factors required for enhancing replication and spread of oncolytic vaccinia virus2015

    • Author(s)
      Horita K, Nakatake M, Goto I, Yamane M, Okazaki M, Parada R, Kurosaki H, Nakamura T
    • Organizer
      The 21st Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      大阪国際会議場(大阪市)
    • Year and Date
      2015-07-25
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] Deletions of both vaccinia growth factor and O1 protein genes enhance therapeutic index of oncolytic vaccinia virus2015

    • Author(s)
      Nakatake M, Yamane M, Horita K, Okazaki M, Roxana Parada R, Hajime Kurosaki H, Nakamura T
    • Organizer
      9th International Conference on Oncolytic Viruses As Cancer Therapeutics
    • Place of Presentation
      Boston Park Plaza Hotel(Boston, USA)
    • Year and Date
      2015-06-15
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] 難治性がんを標的破壊する遺伝子組換えワクシニアウイルスによる全身性がんウイルス療法の開発2015

    • Author(s)
      中村 貴史
    • Organizer
      第74回日本癌学会学術総会
    • Place of Presentation
      名古屋国際会議場(名古屋市)
    • Year and Date
      2015-10-09
    • Data Source
      KAKENHI-PROJECT-15H04310
  • [Presentation] 純和製ワクシニアウイルスを用いた難治がんに対するウイルス療法の開発2015

    • Author(s)
      中村 貴史
    • Organizer
      第23回遺伝子治療推進産学懇話会
    • Place of Presentation
      京都大学東京オフィス(東京都)
    • Year and Date
      2015-04-10
    • Invited
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Presentation] mor-specific, replication-competent vaccinia virus for systemic oncolytic Nakamura T virotherapy2015

    • Author(s)
      Nakamura T
    • Organizer
      The 21st Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      大阪国際会議場(大阪市)
    • Year and Date
      2015-07-24
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Presentation] がん治療に生きたウイルスを利用する~ウイルス感染・増殖の制御に基づくウイルス療法の開発~2014

    • Author(s)
      中村 貴史
    • Organizer
      第10回 霊長類医科学フォーラム
    • Place of Presentation
      文部科学省研究交流センター(つくば市)
    • Year and Date
      2014-11-13
    • Invited
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Presentation] がん治療に生きたウイルスを利用する~ウイルス感染・増殖の制御に基づくウイルス療法の開発~2014

    • Author(s)
      中村 貴史
    • Organizer
      第10回 霊長類医科学フォーラム
    • Place of Presentation
      文部科学省研究交流センター(つくば市)
    • Year and Date
      2014-11-13
    • Invited
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Presentation] DELETIONS OF BOTH VACCINIA GROWTH FACTOR AND O1 PROTEIN GENES ENHANCE THERAPEUTIC INDEX OF ONCOLYTIC VACCINIA VIRUS2014

    • Author(s)
      Naoyoshi Nitta, Ikumi Goto, Motomu Nakatake, Masato Yamane, Kosuke Horita, Hajime Kurosaki and Takafumi Nakamura
    • Organizer
      The 20th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      東京慈恵会医科大学(東京都)
    • Year and Date
      2014-08-08
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Presentation] Tumor-specific, replication-competent and stealth vaccinia virus for systemic oncolytic virotherapy2014

    • Author(s)
      Motomu Nakatake , Takafumi Nakamura
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜市)
    • Year and Date
      2014-09-27
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Presentation] Tumor-specific, replication-competent and stealth vaccinia virus for systemic oncolytic virotherapy2014

    • Author(s)
      Motomu Nakatake , Takafumi Nakamura
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜市)
    • Year and Date
      2014-09-27
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Presentation] Deletions of both vaccinia growth factor and O1 protein genes enhance therapeutic index of oncolytic vaccinia virus2014

    • Author(s)
      Ikumi Goto, Naoyoshi Nitta, Motomu Nakatake, Nao Okada, Masato Yamane, Hajime Kurosaki, Takafumi Nakamura
    • Organizer
      The Seventeenth Annual Meeting of the American Society of Gene & Cell Therapy
    • Place of Presentation
      Marriott Wardman Park(Washington, DC)
    • Year and Date
      2014-05-21
    • Data Source
      KAKENHI-PROJECT-26640103
  • [Presentation] SYSTEMIC CANCER VIROTHERAPY WITH MDVV, A COMBINED miRNA-REGULATED AND THYMIDINE KINASE-DELETED ONCOLYTIC VACCINIA VIRUS2013

    • Author(s)
      Naoyoshi Nitta, Nao Okada, Ikumi Goto, Masato Yamane, Motomu Nakatake, Hajime Kurosaki, Takafumi Nakamura
    • Organizer
      The 19th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      岡山(Oral presentation)
    • Year and Date
      2013-07-04
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] MicroRNA regulation of viral replication for oncolytic virothrapy2013

    • Author(s)
      Nakamura T
    • Organizer
      The 2nd Meeting on RNA and Biofunctions-ASIA Study "RNA Biofunctions and Viruses"
    • Place of Presentation
      ホテルレオパレス博多(福岡)
    • Year and Date
      2013-01-09
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Presentation] Safety profile, tumor selectivity and oncolytic effects after systemic administration of oncolytic vaccinia virus MDVV2013

    • Author(s)
      Takafumi Nakamura
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜(Oral presentation)
    • Year and Date
      2013-10-05
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] MicroRNA regulation of viral replication for oncolytic virothrapy2013

    • Author(s)
      Takafumi Nakamura
    • Organizer
      The 2nd Meeting on RNA and Biofunctions-ASIA Study"RNA Biofunctions and Viruses
    • Place of Presentation
      福岡(Oral presentation)
    • Year and Date
      2013-01-09
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] Systemic cancer virotherapy with MDVV, a combined miRNA-regulated and thymidine kinase-deleted oncolytic vaccinia virus2013

    • Author(s)
      Naoyoshi Nitta, Nao Okada, Ikumi Goto, Motomu Nakatake, Masato Yamane, Hajime Kurosaki, Takafumi Nakamura
    • Organizer
      The Seventh International Meeting On Replicating Oncolytic Virus Therapeutics
    • Place of Presentation
      Quebec City, Canada(Poster presentation)
    • Year and Date
      2013-06-16
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] Systemic cancer therapy with MDVy a combined miKNA.-regulated and thymidine kinase-deleted oncolytic vaccinia virus2012

    • Author(s)
      Nakamura T
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      ロイトン札幌(札幌)
    • Year and Date
      2012-09-19
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Presentation] マイクロRNAによって制御されるウイルスベクターの開発2012

    • Author(s)
      中村貴史
    • Organizer
      第14回日本RNA学会年会
    • Place of Presentation
      仙台(Oral presentation)
    • Year and Date
      2012-07-18
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] SYSTEMIC ONCOLYTIC VIROTHERAPY WITH TUMOR-SPECIFIC REPLICATING VACINIA VIRUSES2012

    • Author(s)
      Nakamura T
    • Organizer
      The 18th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      ホテル熊本テルサ(熊本)
    • Year and Date
      2012-06-29
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Presentation] Systemic cancer virotherapy with MDVV, a combined miRNA-regulated and thymidine kinase-deleted oncolytic vaccinia virus2012

    • Author(s)
      Mina Hikichi, Takafumi Nakamura
    • Organizer
      The 15th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Philadelphia, USA(Poster presentation)
    • Year and Date
      2012-05-17
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] SYSTEMIC ONCOLYTIC VIROTHERAPY WITH TUMOR-SPECIFIC REPLICATING VACINIA VIRUSES2012

    • Author(s)
      Mina Hikichi, Minoru Kidokoro, Hisatoshi Shida, Hideaki Tahara, Takafumi Nakamura
    • Organizer
      The 18th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      熊本(Oral presentation)
    • Year and Date
      2012-06-29
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] Systemic cancer retargeted measles viruses. Virology therapy with MDVV, a combined 454-455 : 237-246, 2014. doi : miRNA-regulated and thymidine kinase-deleted oncolytic vaccinia virus2012

    • Author(s)
      Takafumi Nakamura
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌(Oral presentation)
    • Year and Date
      2012-09-19
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] マイクロRNAによって制御されるウイルスベクターの開発2012

    • Author(s)
      中村貴史
    • Organizer
      第14回日本RNA学会年会
    • Place of Presentation
      北大学百周年記念会館(仙台)
    • Year and Date
      2012-07-18
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Presentation] Systemic cancer virotherapy with MDW, a combined miRNA-regulated and thymidine kinase-deleted oncolytic vaccinia virus2012

    • Author(s)
      Nakamura T
    • Organizer
      The 15th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Pennsylvania Convention Center (Philadelphia, USA)
    • Year and Date
      2012-05-17
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Presentation] Development of tumor-targeting vaccinia viruses as novel oncolytic agents2011

    • Author(s)
      Nakamura T
    • Organizer
      The 17th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      福岡(九州大学医学部百年講堂)
    • Year and Date
      2011-07-17
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] Development of tumor-targeting vaccinia viruses as novel oncolytic agents2011

    • Author(s)
      Takafumi Nakamura, Mina Hikichi, Minoru Kidokoro, Hisatoshi Shida and Hideaki Tahara.
    • Organizer
      The 17th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      福岡
    • Year and Date
      2011-07-17
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] Enhancing therapeutic index of oncolytic vaccinia virus through combining microRNA regulation and thymidine kinase deletion2011

    • Author(s)
      Nakamura T
    • Organizer
      The 14th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Seattle, USA (Washington State Convention & Trade Center)
    • Year and Date
      2011-05-20
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] Development of tumor-targeting vaccinia viruses as novel oncolytic agents2011

    • Author(s)
      Takafumi Nakamura, Mina Hikichi, Minoru Kidokoro, Hisatoshi Shida and Hideaki Tahara.
    • Organizer
      The 17th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      福岡
    • Year and Date
      2011-07-17
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] MicroRNA Regulation of Glycoprotein B5R in Oncolytic Vaccinia Virus Reduces Viral Pathogenicity without Impairing its Antitumor Efficacy2011

    • Author(s)
      Nakamura T
    • Organizer
      The International Union of Microbiological Societies 2011 Congress
    • Place of Presentation
      札幌(札幌コンベンションセンター)
    • Year and Date
      2011-09-12
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] MicroRNA Regulation of Glycoprotein B5R in Oncolytic Vaccinia Virus Reduces Viral Pathogenicity without Impairing its Antitumor Efficacy2011

    • Author(s)
      Mina Hikichi, Minoru Kidokoro, Hisatoshi Shida, Hideaki TaharaandTakafumi Nakamura.
    • Organizer
      The International Union of Microbiological Societies 2011 Congress
    • Place of Presentation
      札幌
    • Year and Date
      2011-09-12
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] MicroRNA Regulation of Oncolytic Vaccinia Virus Reduces Viral Pathogenicity without Impairing its Antitumor Efficacy2011

    • Author(s)
      Nakamura T
    • Organizer
      The 6th International Conference on Oncolytic Viruses As Cancer Therapeutics
    • Place of Presentation
      Las Vegas, U.S.A.(JW Marriott at Summerlin)
    • Year and Date
      2011-03-19
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] MicroRNA Targeting of Oncolytic Viruses for cancer therapy2011

    • Author(s)
      Nakamura T
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋(名古屋国際会議場)
    • Year and Date
      2011-10-04
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] MicroRNA Regulation of Oncolytic Vaccinia Virus Reduces Viral Pathogenicity without Impairing its Antitumor Efficacy2011

    • Author(s)
      Takafumi Nakamura
    • Organizer
      The 6th International Conference on Oncolytic Viruses As Cancer Therapeutics
    • Place of Presentation
      Las Vegas,USA
    • Year and Date
      2011-03-19
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] Enhancing therapeutic index of oncolytic vaccinia virus through combining microRNA regulation and thymidine kinase deletion2011

    • Author(s)
      Mina Hikichi, Minoru Kidokoro, Hisatoshi Shida, Hideaki TaharaandTakafumi Nakamura.
    • Organizer
      The 14th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Seattle,USA
    • Year and Date
      2011-05-20
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] MicroRNA Regulation of Oncolytic Vaccinia Virus Reduces Viral Pathogenicity without Impairing its Antitumor Efficacy2011

    • Author(s)
      Nakamura T
    • Organizer
      The 6th International Conference on Oncolytic Viruses As Cancer Therapeutics
    • Place of Presentation
      Las Vegas, U.S.A.
    • Year and Date
      2011-03-19
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] MicroRNA Targeting of Oncolytic Viruses for cancer therapy2011

    • Author(s)
      Takafumi Nakamura.
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-04
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] Enhancing therapeutic index of oncolytic vaccinia virus through combining micro RNA regulation and thymidine kinase deletion2011

    • Author(s)
      Mina Hikichi, Minoru Kidokoro, Hisatoshi Shida, Hideaki Tahara and Takafumi Nakamura.
    • Organizer
      The 14th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Seattle, USA
    • Year and Date
      2011-05-20
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] MicroRNA Targeting of Oncolytic Viruses for cancer therapy2011

    • Author(s)
      Takafumi Nakamura
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-04
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] MicroRNA Regulation of Glycoprotein B5R in Oncolytic Vaccinia Virus Reduces Viral Pathogenicity without Impairing its Antitumor Efficacy2011

    • Author(s)
      Mina Hikichi, Minoru Kidokoro, Hisatoshi Shida, Hideaki Tahara and Takafumi Nakamura.
    • Organizer
      The International Union of Microbiological Societies 2011 Congress
    • Place of Presentation
      札幌
    • Year and Date
      2011-09-12
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] Highly Attenuated Vaccinia Virus as a Potential Oncolytic Agent for Cancer Virotherapy2010

    • Author(s)
      Nakamura T
    • Organizer
      The 13th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Washington D.C., U.S.A.(Marriott Wardman Park Hotel)
    • Year and Date
      2010-05-22
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] マイクロRNAによって制御されるウイルスの開発とその応用2010

    • Author(s)
      中村貴史
    • Organizer
      第12回日本RNA学会年会
    • Place of Presentation
      東京 一橋記念講堂
    • Year and Date
      2010-07-27
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] MicroRNA-regulated oncolytic vaccinia virus not only enhances the oncolytic activity but also reduces the viral pathogenicity2010

    • Author(s)
      Nakamura T
    • Organizer
      The 16th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      宇都宮 栃木県総合文化センター
    • Year and Date
      2010-07-01
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] マイクロRNAによって制御されるウイルスの開発とその応用2010

    • Author(s)
      中村貴史
    • Organizer
      第12回日本RNA学会年会
    • Place of Presentation
      東京(一橋記念講堂)
    • Year and Date
      2010-07-27
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] Highly Attenuated Vaccinia Virus as a Potential Oncolytic Agent for Cancer Virotherapy2010

    • Author(s)
      Nakamura T
    • Organizer
      The 13th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Washington D.C., U.S.A.
    • Year and Date
      2010-05-22
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] Highly attenuated vaccinia virus with microRNA-regulated oncolysis for cancer virotherapy2010

    • Author(s)
      Takafumi Nakamuravaccinia virus with microRNA-regulated oncolysis for cancer virotherapy. The 13th Annual Meeting of American Society of Gene & Cell Therapy, Washington D.C., USA, 2010/5/20, Oral presentation.
    • Organizer
      The 13th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Washington D.C.,USA
    • Year and Date
      2010-05-20
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] 強い抗癌作用と高い安全性を兼ね備えたマイクロRNA制御増殖型ワクシニアウイルスによる癌ウイルス療法の開発2010

    • Author(s)
      中村貴史
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪 大阪国際会議場 リーガルロイヤルホテル大阪
    • Year and Date
      2010-09-23
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] Highly attenuated vaccinia virus with microRNA-regulated oncolysis for cancer virotherapy2010

    • Author(s)
      Nakamura T
    • Organizer
      The 13th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Washington D.C., U.S.A.(Marriott Wardman Park Hote)
    • Year and Date
      2010-05-20
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] 強い抗癌作用と高い安全性を兼ね備えたマイクロRNA制御増殖型ワクシニアウイルスによる癌ウイルス療法の開発2010

    • Author(s)
      Takafumi Nakamura
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪
    • Year and Date
      2010-09-23
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] Highly Attenuated Vaccinia Virus as a Potential Oncolytic Agent for Cancer Virotherapy2010

    • Author(s)
      Takafumi Nakamura
    • Organizer
      The 13th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Washington D.C.,USA
    • Year and Date
      2010-05-22
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] 強い抗癌作用と高い安全性を兼ね備えたマイクロRNA制御増殖型ワクシニアウイルスによる癌ウイルス療法の開発2010

    • Author(s)
      中村貴史
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪(大阪国際会議場)
    • Year and Date
      2010-09-23
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] Highly attenuated vaccinia virus with microRNA-regulated oncolysis for cancer virotherapy2010

    • Author(s)
      Nakamura T
    • Organizer
      The 13th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Washington D.C., U.S.A.
    • Year and Date
      2010-05-20
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] MicroRNA-regulated oncolytic vaccinia virus not only enhances the oncolytic activity but also reduces the viral pathogenicity2010

    • Author(s)
      Takafumi Nakamura
    • Organizer
      The 16th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      宇都宮
    • Year and Date
      2010-07-01
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] マイクロRNAによって制御されるウイルスの開発とその応用2010

    • Author(s)
      Takafumi Nakamura
    • Organizer
      第12回日本RNA学会年会
    • Place of Presentation
      東京
    • Year and Date
      2010-07-27
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] MicroRNA-regulated oncolytic vaccinia virus not only enhances the oncolytic activity but also reduces the viral pathogenicity2010

    • Author(s)
      Nakamura T
    • Organizer
      The 16th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      宇都宮(栃木県総合文化センター)
    • Year and Date
      2010-07-01
    • Data Source
      KAKENHI-PROJECT-22659227
  • [Presentation] 腫瘍標的ウイルスベクターによる癌治療2007

    • Author(s)
      中村貴史
    • Organizer
      第69回日本血液学会・第49回日本臨床血液学会(合同総会)
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2007-10-11
    • Data Source
      KAKENHI-PROJECT-18799009
  • [Presentation] Systemic cancer therapy with MDVV, a combined miRNA-regulated and thymidine kinase-deleted oncolytic vaccinia virus

    • Author(s)
      Nakamura T
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      ロイトン札幌(札幌)
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] MicroRNA Targeting of Oncolytic Viruses for cancer therapy

    • Author(s)
      Nakamura T
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋国際会議場(名古屋)
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] Safety profile, tumor selectivity and oncolytic effects after systemic administration of oncolytic vaccinia virus MDVV

    • Author(s)
      Naoyoshi Nitta, Nao Okada, Ikumi Goto, Masato Yamane, Motomu Nakatake, Hajime Kurosaki, Takafumi Nakamura
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜(パシフィコ横浜)
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] Development of tumor-targeting vaccinia viruses as novel oncolytic agents

    • Author(s)
      Nakamura T
    • Organizer
      The 17th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      九州大学医学部 百年講堂(福岡)
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] SYSTEMIC CANCER VIROTHERAPY WITH MDVV, A COMBINED miRNA-REGULATED AND THYMIDINE KINASE-DELETED ONCOLYTIC VACCINIA VIRUS

    • Author(s)
      Naoyoshi Nitta, Nao Okada, Ikumi Goto, Masato Yamane, Motomu Nakatake, Hajime Kurosaki, Takafumi Nakamura
    • Organizer
      The 19th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      岡山(岡山コンベンションセンター)
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Presentation] マイクロRNAによって制御されるウイルスベクターの開発

    • Author(s)
      中村貴史
    • Organizer
      第14回日本RNA学会年会
    • Place of Presentation
      北大学百周年記念会館(仙台)
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] Safety profile, tumor selectivity and oncolytic effects after systemic administration of oncolytic vaccinia virus MDVV

    • Author(s)
      Naoyoshi Nitta, Nao Okada, Ikumi Goto, Masato Yamane, Motomu Nakatake, Hajime Kurosaki, Takafumi Nakamura
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜(パシフィコ横浜)
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Presentation] SYSTEMIC ONCOLYTIC VIROTHERAPY WITH TUMOR-SPECIFIC REPLICATING VACINIA VIRUSES

    • Author(s)
      Nakamura T
    • Organizer
      The 18th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      ホテル熊本テルサ(熊本)
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] SYSTEMIC CANCER VIROTHERAPY WITH MDVV, A COMBINED miRNA-REGULATED AND THYMIDINE KINASE-DELETED ONCOLYTIC VACCINIA VIRUS

    • Author(s)
      Naoyoshi Nitta, Nao Okada, Ikumi Goto, Masato Yamane, Motomu Nakatake, Hajime Kurosaki, Takafumi Nakamura
    • Organizer
      The 19th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      岡山(岡山コンベンションセンター)
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] Systemic cancer virotherapy with MDVV, a combined miRNA-regulated and thymidine kinase-deleted oncolytic vaccinia virus

    • Author(s)
      Nakamura T
    • Organizer
      The 15th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Pennsylvania Convention Center (Philadelphia, USA)
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] MicroRNA regulation of viral replication for oncolytic virothrapy

    • Author(s)
      Nakamura T
    • Organizer
      The 2nd Meeting on RNA and Biofunctions-ASIA Study “RNA Biofunctions and Viruses”
    • Place of Presentation
      ホテルレオパレス博多(福岡)
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] Systemic cancer virotherapy with MDVV, a combined miRNA-regulated and thymidine kinase-deleted oncolytic vaccinia virus

    • Author(s)
      Naoyoshi Nitta, Nao Okada, Ikumi Goto, Motomu Nakatake, Masato Yamane, Hajime Kurosaki, Takafumi Nakamura
    • Organizer
      The Seventh International Meeting On Replicating Oncolytic Virus Therapeutics
    • Place of Presentation
      Quebec City, Canada(Chateau Frontenac)
    • Data Source
      KAKENHI-PROJECT-24300340
  • [Presentation] MicroRNA Regulation of Glycoprotein B5R in Oncolytic Vaccinia Virus Reduces Viral Pathogenicity without Impairing its Antitumor Efficacy

    • Author(s)
      Nakamura T
    • Organizer
      The International Union of Microbiological Societies 2011 Congress
    • Place of Presentation
      コンベンションセンター札幌(札幌)
    • Data Source
      KAKENHI-PROJECT-22680065
  • [Presentation] Systemic cancer virotherapy with MDVV, a combined miRNA-regulated and thymidine kinase-deleted oncolytic vaccinia virus

    • Author(s)
      Naoyoshi Nitta, Nao Okada, Ikumi Goto, Motomu Nakatake, Masato Yamane, Hajime Kurosaki, Takafumi Nakamura
    • Organizer
      The Seventh International Meeting On Replicating Oncolytic Virus Therapeutics
    • Place of Presentation
      Quebec City, Canada(Chateau Frontenac )
    • Data Source
      KAKENHI-PROJECT-24650629
  • [Presentation] Enhancing therapeutic index of oncolytic vaccinia virus through combining microRNA regulation and thymidine kinase deletion

    • Author(s)
      Nakamura T
    • Organizer
      The 14th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Washington State Convention & Trade Center (Seattle, USA)
    • Data Source
      KAKENHI-PROJECT-22680065
  • 1.  KATANO HISAKO (50376620)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 2.  TAHARA Hideaki (70322071)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 3.  MATSUSHITA Marimo (50401253)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 4.  KANAMOTO Akira (10386021)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 5.  KATANO Harutaka (70321867)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 6.  Matsumura Yumiko (90594911)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  TANIGUCHI Hiroaki (90563289)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 8.  Kanaji Nobuhiro (60403789)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 9.  坂本 照尚 (00642563)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 10.  神部 敦司 (70348283)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 11.  細谷 朋央 (20721947)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 12.  HASEGAWA kosei
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 13.  加藤 基伸
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 14.  中川原 章
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 15.  中村 洋子
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi